Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing ...

On Thursday, 2257 stocks advanced, 1725 declined and 147 remained unchanged on Bombay Stock Exchange with advance decline ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Scientist.com, the leading R&D procurement-orchestration platform for the life sciences, today announced that its General Counsel, Sarah Harkcom, has been named Innovation Trailblazer at the 2025 ...

New national survey from Huntington Learning Center and YouGov finds overwhelming demand for personalized, supplemental learning programs. ORADELL, NJ / ACCESS Newswire / June 5, 2025 / A new national ...